July 16, 2007
Pharmacosmos participates in the CPhI 2007 Worldwide (International Convention on Pharmaceutical Ingredients and Intermediates). The CPhI 2007 is held at the Fiera Milano Rho Exhibition Centre in Milan, Italy during the period October 2 - 4, 2007.
For additional information about the CPhI 2007, please visit the CPhI Website.
About Pharmacosmos A/S
Pharmacosmos develops and markets
medicines for the treatment of iron deficiency. A research-based
company, its ongoing R&D programme focuses on improving the
treatment options for healthcare professionals and patients
suffering from iron deficiency.
Pharmacosmos is a privately-owned
company and operates in more than 50 countries across Europe, the
Americas and Asia. All its manufacturing is approved by the Danish
Medicines Agency and the US Food & Drug Administration.